Chronic myelogenous leukemia manifested as bilateral proliferative retinopathy.
Mandava
Naresh
N
Costakos
Deborah
D
Bartlett
Heather M
HM
D000328:Adult; D000493:Allopurinol / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001549:Benzamides; D005451:Fluorescein Angiography; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D000068877:Imatinib Mesylate; D017404:In Situ Hybridization, Fluorescence; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D019572:Retinal Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D015861:Retinal Neovascularization / Q000175:diagnosis* / Q000188:drug therapy
D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000493:Allopurinol; D000068877:Imatinib Mesylate; D006918:Hydroxyurea